Data is not available at this time.
Reinsurance Group of America, Incorporated (RGA) operates as a global leader in the reinsurance industry, specializing in life and health reinsurance solutions. The company generates revenue primarily through risk-sharing agreements with insurers, offering products such as longevity reinsurance, disability coverage, and critical illness protection. RGA’s diversified portfolio spans North America, Asia-Pacific, Europe, and other regions, positioning it as a key player in mitigating mortality and morbidity risks for primary insurers. The firm’s deep actuarial expertise and strong underwriting discipline enable it to maintain a competitive edge in a capital-intensive sector. RGA’s market position is reinforced by long-standing client relationships and a reputation for financial stability, allowing it to navigate cyclical demand and regulatory complexities effectively. Its focus on innovation, including data analytics and product customization, further strengthens its ability to address evolving client needs in an increasingly dynamic insurance landscape.
In FY 2024, RGA reported revenue of $21.995 billion, with net income of $717 million, translating to a diluted EPS of $10.73. The company’s operating cash flow stood at $9.37 billion, reflecting strong premium collections and efficient claims management. Notably, RGA’s capital expenditures were negligible, underscoring its asset-light business model and focus on underwriting profitability rather than heavy infrastructure investments.
RGA’s earnings power is driven by its ability to underwrite risks profitably across geographies and product lines. The company’s capital efficiency is evident in its robust operating cash flow, which supports reinvestment and shareholder returns. With no significant capital expenditures, RGA allocates resources primarily to risk management and growth initiatives, ensuring sustainable returns on equity.
RGA maintains a solid balance sheet, with cash and equivalents of $3.326 billion and total debt of $5.042 billion as of FY 2024. The company’s financial health is supported by its strong liquidity position and manageable leverage, enabling it to meet obligations and capitalize on strategic opportunities in the reinsurance market.
RGA has demonstrated consistent growth through geographic expansion and product diversification. The company’s dividend policy reflects its commitment to shareholder returns, with a dividend per share of $1.43752 in FY 2024. This aligns with its stable cash flow generation and disciplined capital allocation strategy.
RGA’s valuation reflects its position as a leading reinsurer with predictable earnings and a resilient business model. Market expectations are anchored on its ability to maintain underwriting discipline and capitalize on growth opportunities in emerging markets, supported by its strong balance sheet and cash flow stability.
RGA’s strategic advantages include its global footprint, actuarial expertise, and strong client relationships. The outlook remains positive, with opportunities in aging populations and increasing demand for reinsurance solutions. However, the company must navigate regulatory changes and competitive pressures to sustain long-term growth.
10-K, investor presentations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |